Close
At the First Symposium of the Serbian Group for Immunodeficiencies, held on April 5, 2025, the expert committee awarded the prize for the best oral case presentation to Dr. Sara Radović from the Clinic of Allergology and Immunology, University Clinical Center of Serbia (UCCS). The award, covering the registration fee for an international congress in the field of immunodeficiencies, was used by Dr. Sara Radović to participate in the ESID–EHA–SIOPE Symposium, which was held from November 18–20 in Vienna, Austria. More details about her participation at this Symposium can be found in the News section.
SGPI Research Grant Award in the Field of Primary Immunodeficiencies
The Serbian Group for Primary Immunodeficiencies (SGPI) announced a call for research grant applications aimed at supporting scientific and research projects in the field of primary immunodeficiencies (PID/IEI) and autoinflammatory diseases, with the goal of fostering research activities and improving diagnostics in this area.
Within this call, a research grant, in the amount of up to EUR 1,000 (paid in the local currency equivalent), was awarded. The grant recipient is Asst. Prof. Maja Stojanović, MD, PhD, for the research project entitled: “Genetic analysis and identification of VEXAS syndrome in patients with unexplained autoinflammatory conditions.”
The awarded funds were used to cover part of the costs related to sending patient samples for genetic analysis to the Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, United Kingdom, in collaboration with Prof. Sinisa Savić, MD, PhD.
The idea for this research project originated during Dr Stojanović’s study visit at St James’s University Hospital in Leeds. During this stay, and with the support of Professor Savić, she had the opportunity to attend an online meeting—the first official meeting of the UK VEXAS Interested Group MDT. This experience played an important role in shaping the research concept and directing the project toward the identification of VEXAS syndrome in patients with unclear autoinflammatory presentations.
Dr Stojanović’s study visit to the United Kingdom was made possible through financial support from the Lilic–Abinun Foundation (Newcastle University), whose mission is to support the advancement of clinical immunology in Serbia.
More information about the foundation is available at the following link: https://www.ncl.ac.uk/medical-sciences/research/serbian-clinical-immunology-fund/.
